AI Content Chat (Beta) logo

Introduction Transforming care Investing in our people Accelerating possibilities Protecting the environment Creating value responsibly Appendix Indicator Description Response 401-3 Parental leave Benefits 403-2 Types of injury and rates of injury, occupational diseases, lost days, Performance Report Appendix, Metrics summary and absenteeism and number of work-related fatalities 404-1 Average hours of training per year per employee Performance Report Appendix, Metrics summary 404-2 Programs for upgrading employee skills and transition Performance Report, Investing in our people, Page 20 assistance programs 404-3 Percentage of employees receiving regular performance and Performance Report, Investing in our people, Page 20 career development reviews 405-1 Diversity of governance bodies and employees Proxy Statement Performance Report Appendix, Metrics summary 405-2 Ratio of basic salary and remuneration of women to men Performance Report, Investing in our people, Page 20 Equal pay for equal work 406-1 Incidents of discrimination and corrective actions taken Compliance and ethics 407-1 Operations and suppliers in which the right to freedom of Human rights association and collective bargaining may be at risk 408-1 Operations and suppliers at significant risk for incidence of Human rights child labor 409-1 Operations and suppliers at significant risk for incidence of forced Human rights or compulsory labor 411-1 Incidents of violations involving rights of Indigenous peoples Human rights 412-1 Operations that have been subject to human rights reviews or Human rights impact assessments 412-2 Employee training on human rights policies or procedures Performance Report, Creating value responsibly, Page 47 Human rights 413-1 Operations with local community engagement, impact Performance Report, Supporting our communities, Page 36 assessments and development programs Community engagement 73 2022 Performance Report

Advancing Science for Life | Boston Scientific - Page 73 Advancing Science for Life | Boston Scientific Page 72 Page 74